Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Aug 10, 2021 12:42pm
130 Views
Post# 33678637

RE:RE:Anonymous

RE:RE:Anonymous
PezDalatoYou wrote: The clock is also ticking on Dr. Kellum's two year leave of absence from UofP. He's almost a quarter into his new 'full time' role at Spectral and is likely getting anxious to start receiving his full compensation. It would be a shame and an embarrassment to head back home to your friends and colleagues with little to show for the previous two years of hard work up at Spectral HQ.


His focus needs to be on getting enrollment up to 10 /month ASAP.  Then there should be plenty of time to complete the task, and get back to the lecture halls. Especially if the Interim data is good.

Although, if the results from the latter enrollee's are as good as the early enrollee's stats are purported to be...he won't need his University position to buy groceries.  The really smart professors figure out how to cash in by "lending their talents to" private industry. 

MM
<< Previous
Bullboard Posts
Next >>